Literature DB >> 11062360

Contributions of bone density and geometry to the strength of the human second metatarsal.

C Muehleman1, R Lidtke, A Berzins, J H Becker, S Shott, D R Sumner.   

Abstract

We investigated, at the whole bone level, the contribution of bone density and geometry to the fracture load of the second metatarsal, a bone that is prone to stress fracture. Dual-energy X-ray absorptiometry (DXA) was used to determine the areal bone mineral density (BMD), projected area of bone, and bone mineral content. Peripheral quantitative computed tomography (pQCT) was used to determine the volumetric cortical bone mineral density (vCtBMD) and cross-sectional moment of interia. Various metatarsal linear dimensions were also measured. The load at failure in cantilever bending was determined. The only linear dimension that had a significant correlation with load at failure was the height of the metatarsal base (r(2) = 0.30, p = 0.008). Utilizing all of the information provided by DXA gave no greater indication of whole bone strength than just BMD alone (adjusted r(2) = 0.40, p = 0.001). Using all of the information provided by pQCT gave no greater indication of whole bone strength than just vCtBMD alone (r(2) = 0. 46, p < 0.001). Volumetric cortical density and BMD were strongly correlated (r(2) = 0.81, p < 0.001). Our data suggest that, in the human second metatarsal, a variable such as material strength (as inferred from cortical density), and not geometry, may be the major factor in determining cantilever load to failure.

Entities:  

Mesh:

Year:  2000        PMID: 11062360     DOI: 10.1016/s8756-3282(00)00370-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports.

Authors:  David J Gutekunst; David R Sinacore
Journal:  J Orthop Sports Phys Ther       Date:  2013-09-09       Impact factor: 4.751

2.  Second metatarsal stress fracture in sport: comparative risk factors between proximal and non-proximal locations.

Authors:  Bavornrit Chuckpaiwong; Chad Cook; Ricado Pietrobon; James A Nunley
Journal:  Br J Sports Med       Date:  2007-03-05       Impact factor: 13.800

3.  Predicting ex vivo failure loads in human metatarsals using bone strength indices derived from volumetric quantitative computed tomography.

Authors:  David J Gutekunst; Tarpit K Patel; Kirk E Smith; Paul K Commean; Matthew J Silva; David R Sinacore
Journal:  J Biomech       Date:  2012-12-06       Impact factor: 2.712

4.  Dual-energy X-ray absorptiometry of human metatarsals: precision, least significant change and association to ex vivo fracture force.

Authors:  Kathryn L Bohnert; David J Gutekunst; Charles F Hildebolt; David R Sinacore
Journal:  Foot (Edinb)       Date:  2013-05-31

5.  Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices.

Authors:  David J Gutekunst; Kirk E Smith; Paul K Commean; Kathryn L Bohnert; Fred W Prior; David R Sinacore
Journal:  Bone       Date:  2012-10-29       Impact factor: 4.398

6.  Computed tomography derived bone density measurement in the diabetic foot.

Authors:  Alex Barwick; John Tessier; James Mirow; Xanne Janse de Jonge; Vivienne Chuter
Journal:  J Foot Ankle Res       Date:  2017-03-03       Impact factor: 2.303

7.  Reproducibility of a peripheral quantitative computed tomography scan protocol to measure the material properties of the second metatarsal.

Authors:  Elodie Chaplais; David Greene; Anita Hood; Scott Telfer; Verona du Toit; Davinder Singh-Grewal; Joshua Burns; Keith Rome; Daniel J Schiferl; Gordon J Hendry
Journal:  BMC Musculoskelet Disord       Date:  2014-07-19       Impact factor: 2.362

8.  A multiscale model to predict current absolute risk of femoral fracture in a postmenopausal population.

Authors:  Pinaki Bhattacharya; Zainab Altai; Muhammad Qasim; Marco Viceconti
Journal:  Biomech Model Mechanobiol       Date:  2018-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.